Accession Number: | 0001209191-21-027558 |
Date: | 2021-04-16 |
Issuer: | TRAVERE THERAPEUTICS, INC. (TVTX) |
Original Submission Date: |
ASELAGE STEVE
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-04-16 | M | 10,000 | a | $16.23 | 198,940 | direct | ||
COMMON STOCK | 2021-04-16 | S | 10,000 | d | $26.23 | 188,940 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 16.23 | 2021-04-16 | deemed execution date | M | 10,000 (d) | 2026-05-18 | common stock 10,000 | $16.23 | 140,000 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to an automatic trading plan adopted in accordance with rule 10b5-1 of the securities exchange act of 1934. |
f2 | the stock option is fully vested and exercisable. |